Bovine adenovirus 3 core protein precursor pVII localizes to mitochondria, and modulates ATP synthesis, mitochondrial Ca2+ and mitochondrial membrane potential

Share Embed


Descripción

Journal of General Virology (2014), 95, 442–452

DOI 10.1099/vir.0.057059-0

Bovine adenovirus 3 core protein precursor pVII localizes to mitochondria, and modulates ATP synthesis, mitochondrial Ca2+ and mitochondrial membrane potential Sanjeev K. Anand,1,2 Amit Gaba,1,2 Jaswant Singh3 and Suresh K. Tikoo1,2,4 Correspondence Suresh K. Tikoo [email protected]

1

Vaccine & Infectious Disease Organization – International Vaccine Center (VIDO-InterVac), University of Saskatchewan, Saskatoon, Canada

2

Veterinary Microbiology, University of Saskatchewan, Saskatoon, Canada

3

Veterinary Biomedical Sciences, University of Saskatchewan, Saskatoon, Canada

4

Vaccinology & Immunotherapeutics Program, School of Public Health, University of Saskatchewan, Saskatoon, Canada

Received 10 July 2013 Accepted 10 October 2013

Viruses modulate the functions of mitochondria by translocating viral proteins to the mitochondria. Subcellular fractionation and sensitivity to proteinase K/Triton X-100 treatment of mitochondrial fractions of bovine adenovirus (BAdV)-3-infected/transfected cells suggested that core protein pVII localizes to the mitochondria and contains a functional mitochondrial localization signal. Moreover, mitochondrial localization of BAdV-3 pVII appears to help in the retention of mitochondrial Ca2+, inducing a significant increase in the levels of ATP and maintaining the mitochondrial membrane potential (MMP) in transfected cells. In contrast, mitochondrial localization of BAdV-3 pVII has no significant effect on the levels of cytoplasmic Ca2+ and reactive oxygen species production in the transfected cells. Consistent with these results, expression of pVII in transfected cells treated with staurosporine decreased significantly the activation of caspase-3. Our results suggested that BAdV-3 pVII localizes to mitochondria, and interferes with apoptosis by inhibiting loss of the MMP and by increasing mitochondrial Ca2+ and ATP production.

INTRODUCTION Mitochondria are vital organelles of the cell that regulate cellular functions and generate energy for all molecular processes (Hackenbrock, 1966; Mannella, 2006; Rapaport, 2003). In addition to energy production, mitochondria also play a central role in Ca2+ buffering, supply of metabolites, regulation of apoptotic factors, ageing and development (Chan, 2006; Hollenbeck & Saxton, 2005). Many viruses alter the structure and function of the mitochondria (Ohta & Nishiyama, 2011), inducing oxidative stress (Huh & Siddiqui, 2002; Machida et al., 2010), the mitochondrial membrane potential (MMP) and the production of ATP (Chang et al., 2009; Monne´ et al., 2007; Su & Hong, 2010) by translocating their proteins to the mitochondria. Although adenovirus replicates in the nucleus of the cell, the possibility of its dependence on mitochondria appears logical. However, little is known about the role of mitochondria in adenovirus infections. Human adenovirus Supplementary material is available with the online version of this paper.

442

(HAdV) has been reported to localize to the mitochondria in cells infected with high-titre virus (Alesci et al., 2007), inducing damage to the mitochondrial architecture. Adenoviral early proteins localize to the mitochondria and either prevent or induce apoptosis (Degenhardt et al., 2000; Lomonosova et al., 2005). Adenovirus protein V interacts with p32 and localizes to the mitochondria (Matthews & Russell, 1998). Adenovirus death protein encoded by the E3 region of HAdV-5 induces oxidative stress and helps in the release of virus progeny from the virus-infected cell (Tollefson et al., 1996). A recent report suggested that HAdV-5 releases cathepsin B activity in the cytoplasm due to endosomal membrane rupture leading to the production of reactive oxygen species (ROS) (McGuire et al., 2011). Bovine adenovirus (BAdV)-3, a member of the genus Mastadenovirus, is a non-enveloped icosahedral virus, which is being developed and evaluated as a vaccine delivery vector for animals (Zakhartchouk et al., 1999) and humans (Rasmussen et al., 1999). The complete DNA sequence and the transcription map of BAdV-3 genome

Downloaded from www.microbiologyresearch.org by 057059 G 2014 SGM IP: 23.22.50.124 On: Mon, 30 May 2016 06:31:20

Printed in Great Britain

BAdV-3 pVII and mitochondria

have been reported (Reddy et al., 1998, 1999). Since mitochondria are major cellular organelles performing various functions, study of the mitochondria/virus interaction may provide new insights into the viral/host interactions. Adenovirus core protein VII is found as a precursor (pVII) in infected cells and as a mature protein (VII) in progeny virions (Hindley et al., 2007). Previous studies suggested that adenovirus core protein VII is involved in the import of the adenovirus genome into the nucleus (Wodrich et al., 2006), protecting it from the Mre11–Rad50–Nbs1 complex at early times after infection (Karen & Hearing, 2011), and may have a role in the

(a)

Mito U I

Cyto Nucl U I U I

Controls U 24 48

Anti-COX-1

Anti-fibrillarin

Anti-ERK

Anti-Hsp70

(b)

Mito U I

Cyto U I

Nucl U I

Controls U 24

Anti-pVII

packaging of DNA in capsids (Zhang & Arcos, 2005). Here, we demonstrated that BAdV-3 pVII localized to mitochondria and appeared to play a beneficial role by modulating mitochondrial functions, including apoptosis.

RESULTS Isolation of mitochondria from bovine cells To determine the localization of BAdV-3 proteins to mitochondria, the mitochondria-rich fraction was purified from mock- or BAdV-3-infected Madin–Darby bovine kidney (MDBK) cells and analysed for purity by Western blotting. Equal amounts of proteins from the mitochondrial fraction, cytoplasmic fraction and nuclear fraction of mock- or BAdV-3-infected cells were separated using 10 % SDS-PAGE, transferred to nitrocellulose membranes and probed with protein-specific antibodies (Fig. 1a). Anticytochrome oxidase (COX)-1 serum detected a specific protein in the mitochondrial fraction but not in the nuclear or cytoplasmic fractions of mock- or BAdV-3infected cells. Anti-extracellular signal-regulated kinase (ERK) serum detected a specific protein in the nuclear fraction and cytoplasmic fractions of mock- or BAdV-3infected cells but not in the mitochondrial fraction. However, anti-fibrillarin serum detected a specific protein

Infected cell total lysate Infected cell Mito. fraction Proteinase K treatment Triton X-100 treatment (a)

– + – –

– + + –

– + + +

+ – – –

Anti-hexokinase

Anti-IVa2 Anti-cll Anti-penton

(b)

Anti-hexon

Anti-hexon

Fig. 1. Western blot analysis of cellular fractions. Proteins from lysates of the indicated cellular fraction isolated from mock- or BAdV-3-infected MDBK cells were separated by SDS-PAGE, transferred to nitrocellulose membranes and probed by Western blotting. (a) Anti-cytochrome oxidase (COX)-1 serum (mitochondrial marker), anti-fibrillarin serum (nuclear marker), anti-extracellular signal-regulated kinase (ERK) serum (cytoplasmic marker) and anti-heat shock protein 70 (Hsp70) serum (loading control). (b) Anti-pVII serum, anti-IVa2 serum, anti-penton serum and antihexon serum. Mitochondrial (Mito), cytosolic (Cyto) and nuclear (Nucl) fractions from uninfected (U) or infected (I) cells. Uninfected MDBK cells (Controls) and BAdV-3-infected MDBK cells collected at 24 or 48 h post-infection (24 or 48). http://vir.sgmjournals.org

Anti-pVII

Anti-penton

Anti-IVa2

Fig. 2. Analysis of mitochondrial (Mito.) fractions from BAdV-3infected MDBK cells. Proteins from the lysates of cellular fractions isolated from BAdV-3-infected cells were treated as indicated and separated using 10 % SDS-PAGE, transferred to nitrocellulose membranes, and probed by Western blotting with (a) antihexokinase mAb and anti-cII mAb, and (b) anti-pVII serum, antihexon serum, anti-penton serum and anti-IVa2 serum.

Downloaded from www.microbiologyresearch.org by IP: 23.22.50.124 On: Mon, 30 May 2016 06:31:20

443

S. K. Anand and others

(a) pVIIMLS 1 54 pcDNA.pVII pEY.VIImls

EYFP

Infected cell total lysate Transfected cell Mito. fraction

– +

– +

– +

+ –

Proteinase K treatment



+

+



Triton X-100 treatment





+



pcDNA3.pVII

Anti-pVII

pEY.VIImls

Anti-pVII

(b) pVIIMLS 1 54

EYFP pEY.VIImls

Oct

DsRed

MLS

pOCT.DsRed

EYFP-VIImls

DAPI

OCT-DsRed

Merge

(c) 1

*; **; **. ; *; ***;

54

; .

.

;

*** *;

*; *;

**

Fig. 3. Analysis of the mitochondria-rich fraction from transfected cells. (a) Schematic diagram of plasmids. The names of the plasmids are given on the left of the panel. Proteins from the lysates of the mitochondrial (Mito.) fraction isolated from cells infected with WT BAdV-3 or transfected with indicated plasmid DNA were treated as indicated, and separated using 10 % SDS-PAGE, transferred to nitrocellulose membranes and probed by Western blotting with protein-specific serum. (b) Vero cells co-transfected with pEY.VIImls and pOCT.DsRed (Harder et al., 2004) were visualized directly under a confocal microscope 48 h after transfection. Nuclei were stained with DAPI. The merger of EYFP-VIImls, OCT-DsRed and DAPI staining is shown.

444

Downloaded from www.microbiologyresearch.org by IP: 23.22.50.124 On: Mon, 30 May 2016 06:31:20

Journal of General Virology 95

BAdV-3 pVII and mitochondria

Fig. 3. cont. (c). Amino acid homology of BAdV-3 pVII-like proteins. Alignment of deduced amino acid sequences of BAdV-3 pVII homologues with those of porcine adenovirus (PAdV)-3 (GenBank accession no. BAA76967), ovine adenovirus (OAdV)A (GenBank accession no. AP_000010), canine adenovirus (CAdV)-1 (GenBank accession no. AP_000055), HAdV-5 (GenBank accession no. AP_000207), HAdV-F (GenBank accession no. NP_040858), HAdV-52 (GenBank accession no. ABK35040), simian adenovirus (SAdV)-48 (GenBank accession no. ADZ39809), HAdV-A (GenBank accession no. YP_002640218), Gorilla gorilla adenovirus B7 (GenBank accession no. ADQ38367) and HAdV-31 (GenBank accession no. CAO78634.1). Identical, strongly conserved and weakly conserved residues are indicated by an asterisk (*), semi-colon (;) and full point (.), respectively. The vertical arrow indicates a potential protease cleavage site.

in the nuclear fraction but not in the cytoplasmic or mitochondrial fractions of mock- or BAdV-3-infected cells. Anti-heat shock protein 70 (Hsp70) serum detected specific protein(s) in all fractions of mock- or BAdV-3infected cells and was used as a loading control. These results suggested that the mitochondrial fractions purified from mock- or BAdV-3-infected cells were enriched highly in mitochondria. BAdV-3 proteins associate with mitochondria To determine if BAdV-3 proteins localize to the mitochondria, proteins from different cellular (mitochondrial, nuclear and cytoplasmic) fractions purified from mockor BAdV-3-infected MDBK cells were separated using 10 % SDS-PAGE and analysed by Western blotting with selected BAdV-3 protein-specific antibodies (Fig. 1b). As seen in Fig. 1(b), anti-IVa2 serum, anti-penton serum and anti-hexon serum recognized specific proteins in BAdV-3-infected cells or purified mitochondrial, cytoplasmic and nuclear fractions of BAdV-3-infected cells. No such proteins could be detected in uninfected cells or purified mitochondrial, cytoplasmic and nuclear fractions of uninfected cells. Similarly, anti-pVII serum recognized specific proteins in BAdV-3-infected cells or purified mitochondrial and nuclear fractions of BAdV-3-infected cells. No such proteins could be detected in purified cytoplasmic BAdV-3-infected cells, uninfected cells or purified mitochondrial and nuclear fractions of uninfected cells. BAdV-3 pVII localizes to mitochondria in BAdV-3infected cells Preliminary studies could not discriminate if the viral proteins localize to the mitochondria on their own due to the presence of the mitochondrial localization signal (MLS; integral membrane proteins and soluble proteins located in the inter-membrane space or matrix) or if they are loosely attached to outer mitochondrial membranes. However, analysis of BAdV-3 protein sequences (GenBank accession no. AF030154) by PSORT and WolfPSORT (Nakai & Horton, 1999), SherLoc (Shatkay et al., 2007) PreDator (Rost et al., 2004), TargetP (Emanuelsson et al., 2007) and MitoProt (Claros & Vincens, 1996) software identified a potential MLS in pVII and pIVa2 but not in hexon or penton. To resolve the issue, mitochondria-rich fractions from BAdV-3-infected MDBK cells were treated with proteinase K and analysed by Western blotting using http://vir.sgmjournals.org

protein-specific antibodies. Proteinase K treatment degrades hexokinase protein (inserted in the outer mitochondrial membrane) but does not degrade complex II protein (inserted in the inner mitochondria membrane). As seen in Fig. 2(a), anti-hexokinase serum detects hexokinase protein in untreated mitochondria or BAdV-3-infected cells but not in proteinase K-treated mitochondria (Fig. 2a). As expected, anti-cII serum detects a complex II protein in untreated mitochondria, BAdV-3-infected cells and also in proteinase K-treated mitochondria (Fig. 2a). To demonstrate that the isolation procedure did not damage mitochondrial integrity, the purified mitochondria were treated with both proteinase K and 0.1 % Triton X-100, and analysed by Western blotting using protein-specific antibodies. This treatment renders proteins contained within the mitochondria (inner membrane and matrix) susceptible to protease treatment (Sardanelli et al., 2006). As expected, anti-cII serum did not detect a complex II protein in proteinase K/Triton X-100-treated mitochondria (which degrades proteins inserted both in the outer and inner membranes). These results reconfirmed and established that proteinase K treatment degrades the proteins exposed on the outer mitochondrial membrane but has no effect on the proteins inside the outer mitochondrial membrane. Next, the mitochondrial fraction isolated from BAdV-3-infected cells was treated with proteinase K in the absence or presence of Triton X100. Treated and untreated mitochondria were analysed by Western blotting using BAdV-3 protein-specific antibodies. As seen in Fig. 2(b), anti-pVII serum detected pVII in proteinase K-treated but not in proteinase K/ Triton X-100-treated mitochondria. In contrast, antihexon serum, anti-penton serum or anti-IVa2 serum did not detect protein-specific bands in proteinase K- or proteinase K/Triton X-100-treated mitochondria. Taken together, these results suggested that whilst IVa2 protein is exposed to the cytosol, pVII is contained within the mitochondria (inner membrane and/or matrix). BAdV-3 pVII localizes to mitochondria in transfected cells To determine if pVII could localize independently to the mitochondria, Vero cells were transfected with 0.4 mg cm22 of the indicated plasmid DNA. After 48 h of transfection, mitochondria-rich fractions isolated from the transfected cells were treated with proteinase K or

Downloaded from www.microbiologyresearch.org by IP: 23.22.50.124 On: Mon, 30 May 2016 06:31:20

445

S. K. Anand and others

BAdV-3 pVII contains a functional MLS Previous protein analysis predicted the presence of a potential MLS at the N-terminus of pVII (aa 1–54) (Fig. 3c). To determine if the MLS was targeting pVII to mitochondria, the DNA encoding the potential pVII MLS (aa 1–54) was fused in-frame to EYFP to create pEY.VIImls (Fig. 3). The mitochondria-rich fractions were isolated from the cells transfected with indicated plasmid DNA, treated with proteinase K or proteinase K/Triton X-100 and analysed by Western blotting using protein-specific antibodies. As seen in Fig. 3(a), both pVII and EY.VIImls fusion protein were resistant to proteinase K treatment but degraded after proteinase K/Triton X-100 treatment. These results suggest that targeting pVII to mitochondria involves the N-terminal 54 aa. Secondly, Vero cells were co-transfected with indicated plasmid DNA and analysed 48 h posttransfection by confocal microscopy. As seen in Fig. 3(b), a portion of recombinant EYFP co-localized with recombinant OCT-DsRed (which localizes only to mitochondria; Harder et al., 2004) in cells co-transfected with pEY.VIImls and pOCT.DsRed, suggesting that recombinant EYFP was localized to the mitochondria of the transfected cells. Interestingly, analysis of the N-terminal 54 aa of BAdV-3 pVII showed significant homology to corresponding proteins of other adenoviruses (Fig. 3).

the cells expressing pVII showed a significant increase in mitochondrial Ca2+ levels, whereas the cells expressing the BAdV-3 protein 100K did not show any significant increase in mitochondrial Ca2+ buffering activity. Thapsigargin treatment of the cells results in a global and transient increase in cytosolic calcium levels (Ong & Hausenloy, 2010), which allowed us to examine the ability of mitochondria to effectively uptake and sequester Ca2+. Following incubation of cells in thapsigargin, Ca2+ is released from the endoplasmic reticulum and is available for uptake by all organelles. In the absence of any stimulus, homeostasis directs Ca2+ back to normal depots (Fig. 5b). Observations were recorded at 100 s intervals to determine if released Ca2+ was taken up by the mitochondria of transfected cells. In normal cells, thapsigargin induces release of Ca2+, which subsides over time (homeostasis). The cells expressing pVII showed a significant sequestration and retention of mitochondrial Ca2+ even after 20 min post-treatment with thapsigargin (1 mM), whereas the cells expressing 100K showed no significant effect in mitochondrial calcium uptake post-treatment with thapsigargin (1 mM) (Fig. 5b). In addition, Vero cells expressing pVII or 100K (Fig. 5c) and exposed to 1 mM thapsigargin (Fig. 5d) showed no significant change in cytosolic Ca2+

(a) 10000 b 8000 ATP (c.p.s.)

proteinase K/Triton X-100 and analysed by Western blotting using protein-specific antibodies. As seen in Fig. 3(a), pVII was detected in proteinase K-treated mitochondria but not in proteinase K/Triton X-100-treated mitochondria. These results confirmed earlier observations and suggested that BAdV-3 pVII localizes inside the mitochondria (inner membrane or matrix) independently of any other viral protein.

6000 4000

a

a

2000

BAdV-3 pVII regulates ATP production Next, we determined if localization of pVII to mitochondria had any effect on the production of ATP in the transfected cells. To observe this, Vero cells were transfected with indicated plasmid DNA and ATP production was measured 48 h post-transfection. ATP concentration was found to be significantly higher in the cells transfected with pcDNA3.pVII DNA compared with that in the cells transfected with pcDNA3 or pcDNA3.100K (Fig. 4a) DNA. This indicated that pVII induced ATP production in the cells and played some role in ATP synthesis. BAdV-3 pVII regulates mitochondrial Ca2+ levels Next, we examined if pVII could regulate the Ca2+ buffering ability of mitochondria of transfected cells. Vero cells were transfected with individual plasmid DNAs, and mitochondrial and cytosolic Ca2+ levels were measured 48 h post-transfection using Fluo-4 AM and Rhod-2 AM, which are highly specific indicators of cellular and mitochondrial Ca2+, respectively. As seen in Fig. 5(a), 446

0 pcDNA3

pcDNA3.pVII pcDNA3.100K

(b) Anti-β-actin Anti-100K Anti-pVII

Fig. 4. ATP production in transfected cells. (a) Vero cells were transfected with individual plasmid DNAs and ATP production measured 48 h post-transfection using the ATPLite 1step kit and a multi-label reader. Measurements are given in arbitrary units [counts per second (c.p.s.)]. Data represent the mean±SEM of two independent experiments, each with three replicates. Means with a different letter are significantly different. *P,0.0001. (b) Proteins from lysates of these transfected cells were also separated using 10 % SDS-PAGE, transferred to nitrocellulose membranes, and probed by Western blotting with anti-b-actin mAb, anti-100K serum and anti-pVII serum.

Downloaded from www.microbiologyresearch.org by IP: 23.22.50.124 On: Mon, 30 May 2016 06:31:20

Journal of General Virology 95

BAdV-3 pVII and mitochondria

(a)

1200

1100

500

1100 1200

1000

–500

900

0 800

pcDNA3.100K

1000

700

pcDNA3 pcDNA3.pVII

1500

600

100

900

pcDNA3 pcDNA3.pVII pcDNA3.100K

500

200

1000

800

700

600

500

400

300

Time post-treatment (s) (d) 2000

300

0

–500

pcDNA3 pcDNA3.pVII pcDNA3.100K

400

400

0

300

500

a

200

(c) Cytosolic Ca2+ (c.p.s.)

0

a

500

100

1000

1000

200

2000

pcDNA3 pcDNA3.pVII pcDNA3.100K

100

b

Cytosolic Ca2+ (c.p.s.)

Mitochondrial Ca2+ (c.p.s.)

3000

Mitochondrial Ca2+ (c.p.s.)

(b) 1500

4000

Time post-treatment (s)

(e) Anti-β-actin Anti-100K Anti-pVII

Fig. 5. Mitochondrial Ca2+ in transfected cells. (a) Vero cells were transfected with individual plasmid DNAs. At 48 h posttransfection, the transfected cells were treated with Rhod-2 AM (Molecular Probes) and analysed for fluorescence using a PerkinElmer multi-label reader (left). (b) The same cells were treated with 1 mM thapsigargin for 30 min and fluorescence measurements were taken for 1200 s post-treatment at 100 s intervals. Measurements are given in arbitrary units (c.p.s.). Data represent the mean±SEM of two independent experiments, each with three replicates. Means with a different letter are significantly different. Means with the same letter are not significantly different. *P,0.0001. (c) Vero cells were transfected with individual plasmid DNAs and cytosolic Ca2+ was measured 48 h post-transfection; the cells were treated with Fluo-4 AM (Molecular Probes) and analysed for fluorescence using a PerkinElmer multi-plate reader. (d) The same cells were treated with 1 mM thapsigargin for 30 min and fluorescence measurements were taken for 1200 s post-treatment at 100 s intervals (right). Measurements are given in arbitrary units (c.p.s). Data represent the mean±SEM of two independent experiments, each with three replicates. Means with the same letter are not significantly different. *P,0.0001. (e) Proteins from the lysates of these transfected cells were also separated using 10 % SDS-PAGE, transferred to nitrocellulose membranes, and probed by Western blotting with anti-b-actin mAb, anti-100K serum and anti-pVII serum.

levels over the period of treatment. This showed that expression of pVII induced mitochondria to sequester and retain Ca2+ compared with those expressing 100K. BAdV-3 pVII regulates the MMP To verify if alterations in mitochondrial Ca2+ caused any changes in the MMP, we measured the MMP in transfected cells using tetramethylrhodamine methyl ester (TMRM). Vero cells were transfected with indicated plasmid DNA and MMP changes were measured 48 h post-transfection (Fig. 6a). TMRM fluorescence levels decreased significantly http://vir.sgmjournals.org

in cells expressing 100K but not in the cells expressing pVII (Fig. 6a). To further confirm the role of pVII in maintaining the MMP, we performed a thapsigargin treatment experiment. As Ca2+ helps to maintain the MMP, thapsigargin treatment should not cause loss of Ca2+ in pVII-expressing cells and thus no loss of Ca2+dependent MMP in these cells. As seen in Fig. 6(b), after thapsigargin treatment there was significant loss of the MMP in cells expressing 100K but not in cells expressing pVII. This indicated that expression of BAdV-3 pVII helped the cells to maintain the MMP, whereas 100K had little or no effect on the maintenance of the MMP.

Downloaded from www.microbiologyresearch.org by IP: 23.22.50.124 On: Mon, 30 May 2016 06:31:20

447

S. K. Anand and others

(a) 1000

b

(b) 150

pcDNA3 pcDNA3.pVII

a

a

400 200

50

1200

1100

900

1000

800

700

600

(c)

–50

500

pcDNA3.pVII pcDNA3.100K

400

pcDNA3

300

0

200

0

pcDNA3.100K

100

100

600

MMP (c.p.s.)

MMP (c.p.s.)

800

Time post-treatment (s)

Anti-β-actin Anti-100K Anti-pVII

Fig. 6. MMP in transfected cells. (a) Vero cells were transfected with individual plasmid DNA, and the MMP was measured 48 h post-transfection using TMRM and a multi-label reader. (b) The same cells were treated with 1 mM thapsigargin for 30 min and measurements were taken for 1200 s post-treatment at 100 s intervals. Data represent the mean±SEM of two independent experiments, each with three replicates. Means with a different letter are significantly different. *P,0.0001. (c) Proteins from these transfected cells were also separated using 10 % SDS-PAGE, transferred to nitrocellulose membranes, and probed by Western blotting with anti-b-actin mAb, anti-100K serum and anti-pVII serum.

BAdV-3 pVII and ROS production in Vero cells To assess mitochondrial function in the cells expressing BAdV-3 pVII or 100K, we measured mitochondrial ROS production in Vero cells transfected with indicated plasmid DNA. At 48 h post-transfection, the cells were incubated with dichlorofluorescein diacetate (DCF-DA) and the fluorescence was quantified (Fig. 7a). The cells transfected with pcDNA3.100K DNA showed a significant increase in the level of ROS production compared with those transfected with pcDNA3 or pcDNA3.pVII, indicating that expression of pVII did not increase oxidative stress levels in Vero cells. BAdV-3 pVII inhibits caspase-3 activation To confirm if pVII induces or inhibits apoptosis, a caspase3 assay was performed. Caspase-3 is an active cell death protease involved in the execution phase of apoptosis (Zou et al., 1997). The caspase-3 assay employs a specific caspase-3 substrate, N-Ac-DEVD-N9-AFC, which upon cleavage by active caspase-3 generates a highly fluorescent product that can be measured using excitation and emission wavelengths of 400 and 505 nm. Vero cells were transfected with indicated plasmid DNA. After 48 h posttransfection, designated cells were treated with staurosporine (a caspase-independent direct activator known to induce apoptosis in cells by blocking the activity of kinases) for 4 h before measuring caspase-3 activity. The data were normalized by measuring the luciferase activity 448

in each sample. As seen in Fig. 8(a), staurosporine treatment of cells transfected with pcDNA3 DNA showed significant activation of caspase-3. Interestingly, expression of pVII did not lead to the activation of caspase-3. In contrast, expression of pVII reduced significantly the activation of caspase-3 in staurosporine-treated cells, suggesting an anti-apoptotic role for pVII.

DISCUSSION A number of viruses target mitochondria during the infection process and alter their functions (Ohta & Nishiyama, 2011). This involves usually the transport of specific viral proteins to the mitochondria, leading to the modulation of mitochondrial functions. We observed previously that BAdV-3 interacted with the mitochondria and altered mitochondrial structure during the course of infection. In the present study, we demonstrated that core protein pVII localizes into the mitochondria and modulates the mitochondrial physiology. Like other viruses, BAdV-3 infection appears to affect mitochondrial functions, including ATP production, mitochondrial Ca2+ concentrations and the MMP. As localization of viral proteins to mitochondria may alter their function, it is tempting to speculate that one or more BAdV-3 protein(s) may be involved in interactions with the mitochondria to help in inducing these processes. Previous amino acid sequence analysis identified that pVII

Downloaded from www.microbiologyresearch.org by IP: 23.22.50.124 On: Mon, 30 May 2016 06:31:20

Journal of General Virology 95

BAdV-3 pVII and mitochondria

(a) 400

(a) 100 000 b

60 000

a

a

40 000 20 000 0 pcDNA3

pcDNA3.pVII

pcDNA3.100K

(b)

b Caspase-3 cleavage (c.p.s.)

ROS (c.p.s.)

80 000

300

200

c 100

Anti-β-actin

a 0

Anti-pVII

pcDNA3

Anti-pVII

d pcDNA3 + S

pcDNA3.pVII pcDNA3.pVII + S

(b) Anti-β-actin

Fig. 7. Induction of ROS in transfected cells. (a) Vero cells were transfected with individual plasmid DNAs. At 48 h post-transfection, the cells were treated with DCF-DA (Molecular Probes) and analysed for fluorescence using a multi-label reader. Measurements are given in arbitrary units (c.p.s). Data represent the mean±SEM of two independent experiments, each with three replicates. Means with a different letter are significantly different. Means with the same letter are not significantly different. *P,0.0001. (b) Proteins from the lysates of these transfected cells were also separated using 10 % SDS-PAGE, transferred to nitrocellulose membranes, and probed by Western blotting with anti-b-actin mAb, anti-100K serum and anti-pVII serum.

contains a potential MLS. However, Western blot analysis of the mitochondrial fraction isolated from infected cells suggested that the all tested proteins appeared to be associated with the mitochondria. It is possible that some of these proteins associate non-specifically with mitochondria due to the effect of virus replication on the distribution of mitochondria in the infected cells. Electron microscopy analysis of infected cells at 12 h post-infection showed the presence of mitochondria in the close vicinity of protein synthesis factories in the infected cells (S. K. Anand & S. K. Tikoo, unpublished observations). These protein(s)-synthesizing factories might be synthesizing viral proteins, which might have been purified with the mitochondrial fraction during the purification process. Of the four BAdV-3 proteins that were found to be associated with mitochondria, only pVII appeared not to be attached loosely, but localized to the mitochondria. Several lines of evidence support the suggestion that pVII localizes to the mitochondria due to the presence of a http://vir.sgmjournals.org

Anti-pVII

Fig. 8. Caspase-3 assay in cells expressing pVII. (a) Vero cells were transfected with individual plasmid DNAs. At 48 h posttransfection, the indicated cells were treated with staurosporine (S) and cleavage of caspase-3 was measured 53 h posttransfection using a multi-label reader. Data represent the mean±SEM of two independent experiments, each with three replicates. Means with a different letter are significantly different. *P,0.0001. (b) Proteins from these transfected cells were also separated using 10 % SDS-PAGE, transferred to nitrocellulose membranes, and probed by Western blotting with anti-b-actin mAb and anti-pVII serum.

functional MLS. (1) pVII-specific proteins could be detected in Western blots of mitochondrial fractions of infected/transfected cells treated with proteinase K. (2) A potential MLS (aa 1–54) could localize the cytoplasmic protein EYFP to the mitochondria of transfected cells. (3) EYFP-VIImls fusion proteins could be detected in Western blots of mitochondrial fractions of transfected cells treated with proteinase K. Localization of viral proteins in mitochondria (Nakai & Horton, 1999) has been implicated in altering various cellular processes, including subverting the host defence mechanisms to establish themselves and replicate (Castanier & Arnoult, 2011), altering Ca2+ homeostasis (Zhou et al., 2009), cellular metabolism (Maynard et al., 2010) and apoptosis (Danthi, 2011). Mitochondrial localization of BAdV-3 pVII induces a significant increase in the levels of ATP, indicating a positive role played by this protein during the course of infection.

Downloaded from www.microbiologyresearch.org by IP: 23.22.50.124 On: Mon, 30 May 2016 06:31:20

449

S. K. Anand and others

Increased ATP is involved in the maintenance of ion gradients and thus the MMP across the mitochondrial membranes (Hollenbeck & Saxton, 2005). pVII also appears to help in the retention of mitochondrial Ca2+ and consistent ATP generation, which help maintain the MMP (Agudo-Lo´pez et al., 2011; Halestrap, 2009, 2010). As Ca2+ is a physiological stimulus for ATP synthesis and is one of the positive effectors of oxidative phosphorylation (Balaban, 2009), it is conceivable that mitochondrial Ca2+ retention helps cells to maintain a steady supply of ATP, thus helping to maintain the MMP. Although pVII helps in the increase and retention of mitochondrial Ca2+, it has little or no effect on cytosolic Ca2+. This may be due to the fact that other Ca2+ stores such as the endoplasmic reticulum, which acts as a main storehouse of Ca2+ in cells, may be releasing enough Ca2+ to maintain cytosolic levels in spite of significant portions of Ca2+ being retained by the mitochondria. Viruses have devised different strategies, including inhibition of cell apoptosis, to facilitate their replication in infected cells. Proteins encoded by several DNA viruses, including vaccinia virus FIL (Wasilenko et al., 2003), Kaposi sarcoma herpesvirus K7 (Wang et al., 2002) or human cytomegalovirus vMIA (Goldmacher et al., 1999), block apoptosis by inhibiting the MMP at the mitochondrial level. Based on our observations, pVII appears to be an anti-apoptotic protein and may help in prolonging the life of the cells, thus helping BAdV-3 to complete its life cycle. Consistent with earlier observations is the fact that (1) pVII has little or no effect on ROS generation in the cells and thus may act as proapoptotic, and (2) expression of pVII in cells treated with staurosporine decreases significantly the activation of caspase-3. Adenovirus mature core protein VII imports viral DNA in the nucleus (Hindley et al., 2007; Wodrich et al., 2006) and protects virion DNA in the nucleus from the DNA damage response at early times after infection (Karen &Hearing, 2011), As a potential MLS of pVII appears to be located at aa 1–54, the predicted mature core protein VII (aa 25–171; Reddy et al., 1998) may contain the MLS (Y. Zhao & S. K. Tikoo, unpublished observations). We speculate that during early stages of infection when the virus needs viable cells, BAdV-3 pVII of infecting virus may localize to mitochondria and help to maintain the life of the cells. An earlier report suggests that adenovirus pVII condenses viral DNA during progeny virus assembly in the nucleus (Hindley et al., 2007). Here, we demonstrate that BAdV-3 pVII also localizes to mitochondria, and appears to be involved in enhancing vital mitochondrial processes and prolonging the longevity of the cell at later stages of virus infection. Thus, pVII appears to be a multifunctional protein, which may be involved in different aspects of adenovirus infection.

METHODS Reagents. Lipofectamine 2000 (Invitrogen), the mitochondria

isolation kit for mammalian cells (Pierce), BCIP/nitro blue tetrazolium 450

(NBT) reagent and staurosporine (Sigma), the Dual-Luciferase Reporter Assay System (Promega), ATPLite 1step kit reagents (PerkinElmer), Rhod-2 AM, Fluo-4 AM and TMRM (Molecular Probes), minimal essential medium (MEM; Invitrogen), and Dulbecco’s modified Eagle’s medium (DMEM; Sigma) were used as described by the manufacturer’s. Assays used either a multi-label counter (Victor X3; PerkinElmer) or confocal microscope (TCS-SP5; Leica). Cell lines and virus. MDBK cells were grown in MEM supplemented

with 10 % heat-inactivated FBS. WT BAdV-3 (WBR-1 strain) was propagated in MDBK cells in MEM supplemented with 2 % FBS (Reddy et al., 1998). Vero cells were propagated in DMEM supplemented with 10 % FBS. Antibodies. Anti-penton and anti-hexon sera detect proteins of 62

and 98 kDa, respectively, in BAdV-3-infected cells (Kulshreshtha et al., 2004). Anti-pVII serum recognizes two proteins of 22 and 20 kDa in BAdV-3-infected cells (Paterson, 2010). Anti-IVa2 serum recognizes a protein of 55 kDa in BAdV-3-infected cells (A. Gaba & S. K. Tikoo, unpublished observations). Anti-100K serum recognizes a protein of 130K in BAdV-3-infected cells (Kulshreshtha & Tikoo, 2008). mAb specific to hexokinase and polyclonal antibodies specific to ERK2 and fibrillarin were purchased from Santa Cruz Biotechnology. mAb specific to COX-1 was purchased from Invitrogen, mAb specific to Hsp70 was purchased from Stressgen, mAb specific to mitochondrial complex II subunit was purchased from Mitosciences. mAb specific to b-actin was purchased from Sigma. Alkaline phosphatase (AP)conjugated goat anti-rabbit IgG and AP-conjugated goat anti-mouse antibody were purchased from Jackson ImmunoResearch. Plasmid construction. pOCT.DsRed (Harder et al., 2004) was a gift from Dr H. McBride (University of Ottawa). The construction of pcDNA.100K has been described previously (Kulshreshtha & Tikoo, 2008). The other plasmids (supplementary File S1, available in JGV Online) were constructed using standard procedures. Isolation of mitochondria. MDBK cells were infected with BAdV-3

at a m.o.i. of 5. Vero cells were transfected with individual plasmid DNAs (0.4 mg cm22) using Lipofectamine 2000. At indicated times post-infection or transfection, the cells were collected and used for isolation of mitochondria using the mitochondria isolation kit for mammalian cells as per the manufacturer’s instructions with some modifications. Approximately 26107 MDBK cells (mock or infected) or Vero cells (mock or plasmid-transfected) were Dounce homogenized and pelleted at 300 g to collect the cell debris and nuclei. Supernatant 1 was collected, and the pellet containing the cell debris and nucleus was dissolved in nucleus isolation buffer [10 mM KCl, 10 mM MgCl2, 10 mM Tris/HCl (pH 7.4) and 10 mM DDT], further homogenized in a Dounce homogenizer, and finally centrifuged at 212 g to obtain the nuclear fraction. Supernatant 1 was centrifuged at 3200 g to pellet the mitochondria-enriched fraction. The resulting supernatant 2 left after isolation of the mitochondria-enriched fraction was used as the cytoplasmic fraction. Western blot analysis. MDBK cells infected with WT BAdV-3 at an

m.o.i. of 5 were harvested at indicated times post-infection. Vero cells were transfected with individual plasmid DNA (0.4 mg cm22) using Lipofectamine 2000 and harvested at indicated times post-transfection. Proteins from the lysates of cells, mitochondria, cytoplasmic or nuclear fractions were separated using 10 % SDS-PAGE and analysed by Western blotting as described previously (Kulshreshtha & Tikoo, 2008). Proteinase K treatment. The isolated mitochondria were dissolved in buffer C of the mitochondria isolation kit with or without Triton X-100 containing proteinase K at a final concentration 150 mg ml21.

Downloaded from www.microbiologyresearch.org by IP: 23.22.50.124 On: Mon, 30 May 2016 06:31:20

Journal of General Virology 95

BAdV-3 pVII and mitochondria The treated samples were incubated for 30 min on ice before centrifugation at 6700 g for 15 min at 4 uC (Huh & Siddiqui, 2002). The pellet fraction(s) was subsequently analysed by Western blotting using protein-specific antibodies.

SAS) for effect of treatment (DNA transfection). P.0.05 was considered non-significant. Tukey’s post-hoc tests for multiple comparisons were performed if the main effect was significant (P¡0.05). The values are expressed as mean±SEM.

Cellular ATP. Vero cells grown in 96-well plates were transfected with indicated plasmid DNA (0.2 mg per well) using Lipofectamine

ACKNOWLEDGEMENTS

2000. At indicated times post-infection or transfection, the cells were treated with ATPLite 1step kit reagents. The emitted light, which is proportional to the ATP concentration, was recorded using a multilabel counter. Mitochondrial and cytosolic Ca2+. Vero cells grown in 96-well plates were transfected with indicated plasmid DNA (0.2 mg per well)

using Lipofectamine 2000. At indicated times post-infection or transfection, the cells were incubated with 5 mM mitochondrial Ca2+sensitive dye Rhod-2 AM or 10 mM cytosolic Ca2+-sensitive dye Fluo-4 AM for 30 min at 37 uC. The cells were washed three times in Ca2+-free PBS or KRH buffer [129 mM NaCl, 5 mM NaHCO3, 4.8 mM KCl, 1.2 mM KH2PO4, 1 mM CaCl2, 1.2 mM MgCl2, 2.8 mM glucose and 10 mM HEPES (pH 7.4)] and equilibrated for 10 min. Fluorescence signals were detected using a multi-label counter using a 480/31 nm filter to excite the Fluo-4 AM fluorescence and 531 nm filter to excite Rhod-2 AM fluorescence. The signals were detected at 535 (Fluo-4 AM) and 572 nm (Rhod-2 AM). MMP. Vero cells grown in 96-well plates were transfected with 0.2 mg

per well of indicated plasmid DNA using Lipofectamine 2000. At indicated times post-infection or transfection, the cells were incubated for 30 min with 100 nM TMRM in KRH-glucose buffer containing 0.02 % pluronic acid, then washed and allowed to equilibrate for 20 min. Fluorescence signals were measured using a multi-label counter with a 531 nm excitation and 572 nm emission filter. Mitochondrial ROS. Vero cells grown in 96-well plates were transfected with 0.2 mg per well of indicated plasmid DNA using

Lipofectamine 2000. At indicated times post-transfection, the cells were incubated with 10 mM DCF-DA (Degli Esposti, 2002) and incubated for 30 min in KRH buffer. Finally, the cells were washed three times in KRH buffer and equilibrated for 10 min. Fluorescence signals were measured using a multi-label counter with 480/31 nm excitation and 535 (DCF-DA) and 580 nm emission filters.

The authors thank members of the Tikoo laboratory for their suggestions and staff of the Animal Care Unit with production of antiserum. Published as VIDO article no. 635. The work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada to S. K. T.

REFERENCES Agudo-Lo´pez, A., Miguel, B. G., Ferna´ndez, I. & Martı´nez, A. M. (2011). Role of protein kinase C and mitochondrial permeability

transition pore in the neuroprotective effect of ceramide in ischemiainduced cell death. FEBS Lett 585, 99–103. Alesci, S., Abu-Asab, M., Perera, S. M., Tsokos, M., Morris, J. C. & Pacak, K. (2007). Mitochondrial localization of human recombinant

adenovirus: from evolution to gene therapy. Neuroimmunomodulation 14, 221–223. Ascombe, F. J. (1948). The validity of comparative experiments. J R Stat Soc [Ser A] 111, 181–211. Balaban, R. S. (2009). The role of Ca2+ signaling in the coordination

of mitochondrial ATP production with cardiac work. Biochim Biophys Acta 1787, 1334–1341. Castanier, C. & Arnoult, D. (2011). Mitochondrial localization of viral

proteins as a means to subvert host defense. Biochim Biophys Acta 1813, 575–583. Chan, D. C. (2006). Mitochondria: dynamic organelles in disease,

aging, and development. Cell 125, 1241–1252. Chang, C. W., Li, H. C., Hsu, C. F., Chang, C. Y. & Lo, S. Y. (2009).

Increased ATP generation in the host cell is required for efficient vaccinia virus production. J Biomed Sci 16, 80. Claros, M. G. & Vincens, P. (1996). Computational method to predict

mitochondrially imported proteins and their targeting sequences. Eur J Biochem 241, 779–786. Danthi, P. (2011). Enter the kill zone: initiation of death signaling

Confocal microscopy. Vero cells seeded in two-well glass chamber slides were transfected with indicated plasmid DNA (0.8 mg per well)

using Lipofectamine 2000. At indicated times post-transfection, the cells were mounted in Citifluor and visualized using a confocal microscope (TCS-SP5). Apoptosis assay. Vero cells in one well (16105 per well) of a 24well plate were co-transfected with 0.8 mg per well of plasmid phRL Renilla luciferase DNA and 0.8 mg per well of indicated plasmid DNA

using Lipofectamine 2000. After indicated times post-transfection, selected samples were treated with 500 nM staurosporine for 4 h. The treated transfected cells were washed with PBS, lysed and incubated for 1 h in reaction buffer containing DEVD-AFC substrate to determine the cleavage of caspase-3 by measuring the generated fluorescent product using a multi-label counter. Expression of Renilla luciferase was measured using the Dual-Luciferase Reporter Assay System. The results were normalized and plotted as mean of six independent readings.

during virus entry. Virology 411, 316–324. Degenhardt, K., Perez, D. & White, E. (2000). Pathways used by

adenovirus E1B 19K to inhibit apoptosis. Symp Soc Exp Biol 52, 241– 251. Degli Esposti, M. (2002). Measuring mitochondrial reactive oxygen

species. Methods 26, 335–340. Emanuelsson, O., Brunak, S., von Heijne, G. & Nielsen, H. (2007).

Locating proteins in the cell using TarhetP, SignalP and related tools. Nature Protocol 2, 953–971. Goldmacher, V. S., Bartle, L. M., Skaletskaya, A., Dionne, C. A., Kedersha, N. L., Vater, C. A., Han, J. W., Lutz, R. J., Watanabe, S. & other authors (1999). A cytomegalovirus-encoded mitochondria-

localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A 96, 12536–12541. Hackenbrock, C. R. (1966). Ultrastructural bases for metabolically

Statistical analysis. Data were analysed by one-way ANOVA

linked mechanical activity in mitochondria. I. Reversible ultrastructural changes with change in metabolic steady state in isolated liver mitochondria. J Cell Biol 30, 269–297.

(Ascombe, 1948) using a general linear model procedure (SAS Enterprise Guide 4.2 under SAS 9.2 environment for Windows XP;

Halestrap, A. P. (2009). What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 46, 821–831.

http://vir.sgmjournals.org

Downloaded from www.microbiologyresearch.org by IP: 23.22.50.124 On: Mon, 30 May 2016 06:31:20

451

S. K. Anand and others Halestrap, A. P. (2010). A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. Biochem Soc Trans 38, 841–860.

Rapaport, D. (2003). Finding the right organelle. Targeting signals in

mitochondrial outer-membrane proteins. EMBO Rep 4, 948–952.

Harder, Z., Zunino, R. & McBride, H. (2004). Sumo1 conjugates

Rasmussen, U. B., Benchaibi, M., Meyer, V., Schlesinger, Y. & Schughart, K. (1999). Novel human gene transfer vectors: evaluation

mitochondrial substrates and participates in mitochondrial fission. Curr Biol 14, 340–345.

of wild-type and recombinant animal adenoviruses in human-derived cells. Hum Gene Ther 10, 2587–2599.

Hindley, C. E., Lawrence, F. J. & Matthews, D. A. (2007). A role for

Reddy, P. S., Idamakanti, N., Zakhartchouk, A. N., Baxi, M. K., Lee, J. B., Pyne, C., Babiuk, L. A. & Tikoo, S. K. (1998). Nucleotide

transportin in the nuclear import of adenovirus core proteins and DNA. Traffic 8, 1313–1322. Hollenbeck, P. J. & Saxton, W. M. (2005). The axonal transport of

mitochondria. J Cell Sci 118, 5411–5419. Huh, K. W. & Siddiqui, A. (2002). Characterization of the mitochondrial association of hepatitis B virus X protein, HBx. Mitochondrion 1, 349–359. Karen, K. A. & Hearing, P. (2011). Adenovirus core protein VII

protects the viral genome from a DNA damage response at early times after infection. J Virol 85, 4135–4142. Kulshreshtha, V. & Tikoo, S. K. (2008). Interaction of bovine

adenovirus-3 33K protein with other viral proteins. Virology 381, 29– 35. Kulshreshtha, V., Babiuk, L. A. & Tikoo, S. K. (2004). Role of bovine

adenovirus-3 33K protein in viral replication. Virology 323, 59–69. Lomonosova, E., Subramanian, T. & Chinnadurai, G. (2005).

Mitochondrial localization of p53 during adenovirus infection and regulation of its activity by E1B-19K. Oncogene 24, 6796–6808. Machida, K., McNamara, G., Cheng, K. T., Huang, J., Wang, C. H., Comai, L., Ou, J. H. & Lai, M. M. (2010). Hepatitis C virus inhibits

DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes. J Immunol 185, 6985–6998. Mannella, C. A. (2006). Structure and dynamics of the mitochondrial

inner membrane cristae. Biochim Biophys Acta 1763, 542–548. Matthews, D. A. & Russell, W. C. (1998). Adenovirus core protein V

interacts with p32 – a protein which is associated with both the mitochondria and the nucleus. J Gen Virol 79, 1677–1685. Maynard, N. D., Gutschow, M. V., Birch, E. W. & Covert, M. W. (2010).

The virus as metabolic engineer. Biotechnol J 5, 686–694. McGuire, K. A., Barlan, A. U., Griffin, T. M. & Wiethoff, C. M. (2011).

Adenovirus type 5 rupture of lysosomes leads to cathepsin Bdependent mitochondrial stress and production of reactive oxygen species. J Virol 85, 10806–10813. Monne´, M., Robinson, A. J., Boes, C., Harbour, M. E., Fearnley, I. M. & Kunji, E. R. (2007). The mimivirus genome encodes a mitochondrial

carrier that transports dATP and dTTP. J Virol 81, 3181–3186. a program for detecting sorting signals in proteins and predicting their subcellular localization. Trends Biochem Sci 24, 34–35.

Nakai, K. & Horton, P. (1999).

PSORT:

sequence, genome organization, and transcription map of bovine adenovirus type 3. J Virol 72, 1394–1402. Reddy, P. S., Chen, Y., Idamakanti, N., Pyne, C., Babiuk, L. A. & Tikoo, S. K. (1999). Characterization of early region 1 and pIX of bovine

adenovirus-3. Virology 253, 299–308. Rost, B., Yachdav, G. & Liu, J. (2004). The PredictProtein server.

Nucleic Acids Res 32 (Web Server issue), W321–W326. Sardanelli, A. M., Signorile, A., Nuzzi, R., Rasmo, D. D., TechnikovaDobrova, Z., Drahota, Z., Occhiello, A., Pica, A. & Papa, S. (2006).

Occurrence of A-kinase anchor protein and associated cAMPdependent protein kinase in the inner compartment of mammalian mitochondria. FEBS Lett 580, 5690–5696. Shatkay, H., Ho¨glund, A., Brady, S., Blum, T., Do¨nnes, P. & Kohlbacher, O. (2007). SherLoc: high-accuracy prediction of protein

subcellular localization by integrating text and protein sequence data. Bioinformatics 23, 1410–1417. Su, Y. C. & Hong, J. R. (2010). Betanodavirus B2 causes ATP

depletion-induced cell death via mitochondrial targeting and complex II inhibition in vitro and in vivo. J Biol Chem 285, 39801–39810. Tollefson, A. E., Ryerse, J. S., Scaria, A., Hermiston, T. W. & Wold, W. S. (1996). The E3-11.6-kDa adenovirus death protein (ADP) is

required for efficient cell death: characterization of cells infected with adp mutants. Virology 220, 152–162. Wang, H. W., Sharp, T. V., Koumi, A., Koentges, G. & Boshoff, C. (2002). Characterization of an anti-apoptotic glycoprotein encoded

by Kaposi’s sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. EMBO J 21, 2602–2615. Wasilenko, S. T., Stewart, T. L., Meyers, A. F. A. & Barry, M. (2003).

Vaccinia virus encodes a previously uncharacterized mitochondrialassociated inhibitor of apoptosis. Proc Natl Acad Sci U S A 100, 14345–14350. Wodrich, H., Cassany, A., D’Angelo, M. A., Guan, T., Nemerow, G. & Gerace, L. (2006). Adenovirus core protein pVII is translocated into

the nucleus by multiple import receptor pathways. J Virol 80, 9608– 9618. Zakhartchouk, A. N., Pyne, C., Mutwiri, G. K., Papp, Z., Baca-Estrada, M. E., Griebel, P., Babiuk, L. A. & Tikoo, S. K. (1999). Mucosal

immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1. J Gen Virol 80, 1263–1269.

Mitochondrion 11, 1–12.

Zhang, W. & Arcos, R. (2005). Interaction of the adenovirus major core protein precursor, pVII, with the viral DNA packaging machinery. Virology 334, 194–202.

Ong, S. B. & Hausenloy, D. J. (2010). Mitochondrial morphology and

Zhou, Y., Frey, T. K. & Yang, J. J. (2009). Viral calciomics: interplays

cardiovascular disease. Cardiovasc Res 88, 16–29.

between Ca2+ and virus. Cell Calcium 46, 1–17.

Paterson, C. P. (2010). Molecular characterization of 52K protein of

Zou, H., Henzel, W. J., Liu, X., Lutschg, A. & Wang, X. (1997). Apaf-1, a

bovine adenovirus type 3. PhD thesis, University of Saskatchewan, Saskatoon, Canada.

human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405–413.

Ohta, A. & Nishiyama, Y. (2011). Mitochondria and viruses.

452

Downloaded from www.microbiologyresearch.org by IP: 23.22.50.124 On: Mon, 30 May 2016 06:31:20

Journal of General Virology 95

Lihat lebih banyak...

Comentarios

Copyright © 2017 DATOSPDF Inc.